An Allosteric Modulator of α7 Nicotinic Receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N′-(5-methyl-3-isoxazolyl)-urea (PNU-120596), Causes Conformational Changes in the Extracellular Ligand Binding Domain Similar to Those Caused by Acetylcholine
Authors:
- James T. McLaughlinJMJames T. McLaughlin
- Jennifer A. SeeJSJennifer A. See
- Vanessa L. RichardsVRVanessa L. Richards
- Robert L. RosenbergRRRobert L. Rosenberg
- 1 August 2009
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 76 (2) , 253-263
Abstract
Nicotinic acetylcholine receptors are implicated in several neuropsychiatric disorders, including nicotine addiction, Alzheimer9s, schizophrenia, and depression. Therefore, they represent a critical molecular target for drug development and targeted therapeutic intervention. Understanding the molecular mechanisms by which allosteric modulators enhance activation of these receptors is crucial to the development of new drugs. We used the substituted cysteine accessibility method to study conformational changes induced by the positive allosteric modulator N-(5-chloro-2,4-dimethoxyphenyl)-N′-(5-methyl-3-isoxazolyl)-urea (PNU-120596) in the extracellular ligand binding domain of α7 nicotinic receptors carrying the L247T mutation. PNU-120596 caused changes in cysteine accessibility at the inner beta sheet, transition zone, and agonist binding site. These changes in accessibility are similar to but not identical to those caused by ACh alone. In particular, PNU-120596 induced changes in MTSEA accessibility at N170C (in the transition zone) that were substantially different from those evoked by acetylcholine (ACh). We found that PNU-120596 induced changes at position E172C in the absence of allosteric modulation. We identified a cysteine mutation of the agonist binding site (W148C) that exhibited an unexpected phenotype in which PNU-120596 acts as a full agonist. In this mutant, ACh-evoked currents were more sensitive to thiol modification than PNU-evoked currents, suggesting that PNU-120596 does not bind at unoccupied agonist-binding sites. Our results provide evidence that binding sites for PNU-120596 are not in the agonist-binding sites and demonstrate that positive allosteric modulators such as PNU-120596 enhance agonist-evoked gating of nicotinic receptors by eliciting conformational effects that are similar but nonidentical to the gating conformations promoted by ACh.Keywords
This publication has 40 references indexed in Scilit:
- Conformational changes in α7 acetylcholine receptors underlying allosteric modulation by divalent cationsBMC Pharmacology, 2009
- Unliganded gating of acetylcholine receptor channelsProceedings of the National Academy of Sciences, 2009
- Agonist‐ and antagonist‐induced conformational changes of loop F and their contributions to the ρ1 GABA receptor functionThe Journal of Physiology, 2009
- Potentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane siteProceedings of the National Academy of Sciences, 2008
- A conserved salt bridge critical for GABAAreceptor function and loop C dynamicsProceedings of the National Academy of Sciences, 2008
- Individually Monitoring Ligand-Induced Changes in the Structure of the GABAA Receptor at Benzodiazepine Binding Site and Non-Binding-Site InterfacesMolecular Pharmacology, 2008
- Aromatic residues at position 55 of rat α7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitizationThe Journal of Physiology, 2008
- Gating of nicotinic ACh receptors; new insights into structural transitions triggered by agonist binding that induce channel openingThe Journal of Physiology, 2007
- RIC-3 Enhances Functional Expression of Multiple Nicotinic Acetylcholine Receptor Subtypes in Mammalian CellsMolecular Pharmacology, 2005
- Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channelNature, 2004